Page 1854 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 107 Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies 1649.e1

REFERENCES 22. Eapen M, Rocha V, Sanz G, et al: Effect of graft source on unrelated
donor haemopoietic stem-cell transplantation in adults with acute
1. Broxmeyer HE, Douglas GW, Hangoc G, et al: Human umbilical leukaemia: a retrospective analysis. Lancet Oncol 11(7):653–660, 2010.
cord blood as a potential source of transplantable hematopoietic 23. Kurtzberg J, Prasad VK, Carter SL, et al: Results of the Cord Blood
stem/progenitor cells. Proc Natl Acad Sci USA 86(10):3828–3832, Transplantation Study (COBLT): clinical outcomes of unrelated donor
1989. umbilical cord blood transplantation in pediatric patients with hema-
2. Gluckman E, Broxmeyer HA, Auerbach AD, et al: Hematopoietic tologic malignancies. Blood 112(10):4318–4327, 2008.
reconstitution in a patient with Fanconi’s anemia by means of 24. Laughlin MJ, Eapen M, Rubinstein P, et al: Outcomes after transplan-
umbilical-cord blood from an HLA-identical sibling. N Engl J Med tation of cord blood or bone marrow from unrelated donors in adults
321(17):1174–1178, 1989. with leukemia. N Engl J Med 351(22):2265–2275, 2004.
3. Gluckman E, Ruggeri A, Volt F, et al: Milestones in umbilical cord 25. Takahashi S, Ooi J, Tomonari A, et al: Comparative single-institute
blood transplantation. Br J Haematol 154(4):441–447, 2011. analysis of cord blood transplantation from unrelated donors with bone
4. Wagner JE, Gluckman E: Umbilical cord blood transplantation: the marrow or peripheral blood stem-cell transplants from related donors
first 20 years. Semin Hematol 47(1):3–12, 2010. in adult patients with hematologic malignancies after myeloablative
5. Kurtzberg J, Laughlin M, Graham ML, et al: Placental blood as a conditioning regimen. Blood 109(3):1322–1330, 2007.
source of hematopoietic stem cells for transplantation into unrelated 26. Eapen M, Rubinstein P, Zhang MJ, et al: Outcomes of transplantation
recipients. N Engl J Med 335(3):157–166, 1996. of unrelated donor umbilical cord blood and bone marrow in children
6. Wagner JE, Rosenthal J, Sweetman R, et al: Successful transplantation with acute leukaemia: a comparison study. Lancet 369(9577):1947–
of HLA-matched and HLA-mismatched umbilical cord blood from 1954, 2007.
unrelated donors: analysis of engraftment and acute graft-versus-host 27. Eapen M, Klein JP, Sanz GF, et al: Effect of donor-recipient HLA
disease. Blood 88(3):795–802, 1996. matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord
7. Gluckman E: Milestones in umbilical cord blood transplantation. Blood blood transplantation for leukaemia and myelodysplastic syndrome: a
Rev 25(6):255–259, 2011. retrospective analysis. Lancet Oncol 12(13):1214–1221, 2011.
8. Pasquini MC, Zhu X: Current use and outcome of hematopoietic 28. Eapen M, Klein JP, Ruggeri A, et al: Impact of allele-level HLA match-
stem cell transplantation. CIBMTR Summary Slides, 2014. Available ing on outcomes after myeloablative single unit umbilical cord blood
at: <http://www.cibmtr.org>, 2014. transplantation for hematologic malignancy. Blood 123(1):133–140,
9. Barker JN, Krepski TP, DeFor TE, et al: Searching for unrelated donor 2014.
hematopoietic stem cells: availability and speed of umbilical cord blood 29. Rocha V, Labopin M, Sanz G, et al: Transplants of umbilical-cord blood
versus bone marrow. Biol Blood Marrow Transplant 8(5):257–260, or bone marrow from unrelated donors in adults with acute leukemia.
2002. N Engl J Med 351(22):2276–2285, 2004.
10. National Marrow Donor Program a contractor for the C.W. Bill Young 30. Oran B, Shpall EJ: Allele-level HLA cord blood matching matters.
Cell Transplantation Program operated through the U.S. Department of Blood 123(1):8–9, 2014.
Health and Human Services HRaS. Transplant Data. 2013; <http:// 31. Atsuta Y, Suzuki R, Nagamura-Inoue T, et al: Disease-specific analyses
bloodcell.transplant.hrsa.gov/research/registry_data/index.html#Fig4>. of unrelated cord blood transplantation compared with unrelated bone
11. Gragert L, Eapen M, Williams E, et al: HLA match likelihoods for marrow transplantation in adult patients with acute leukemia. Blood
hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med 113(8):1631–1638, 2009.
371(4):339–348, 2014. 32. Mathe G, Amiel JL, Schwarzenberg L, et al: Bone marrow transplanta-
12. Barker JN, Scaradavou A, Stevens CE: Combined effect of total tion in man. Transplant Proc 1(1):16–24, 1969.
nucleated cell dose and HLA match on transplantation outcome in 33. Ende M, Ende N: Hematopoietic transplantation by means of fetal
1061 cord blood recipients with hematologic malignancies. Blood (cord) blood. A new method. Va Med Mon (1918) 99(3):276–280,
115(9):1843–1849, 2010. 1972.
13. Gluckman E, Rocha V: Donor selection for unrelated cord blood 34. Barker JN, Weisdorf DJ, DeFor TE, et al: Transplantation of 2 partially
transplants. Curr Opin Immunol 18(5):565–570, 2006. HLA-matched umbilical cord blood units to enhance engraftment in
14. Gluckman E, Rocha V, Arcese W, et al: Factors associated with out- adults with hematologic malignancy. Blood 105(3):1343–1347, 2005.
comes of unrelated cord blood transplant: guidelines for donor choice. 35. Barker JN, Weisdorf DJ, DeFor TE, et al: Rapid and complete donor
Exp Hematol 32(4):397–407, 2004. chimerism in adult recipients of unrelated donor umbilical cord
15. Gluckman E, Rocha V, Boyer-Chammard A, et al: Outcome of cord- blood transplantation after reduced-intensity conditioning. Blood
blood transplantation from related and unrelated donors. Eurocord 102(5):1915–1919, 2003.
Transplant Group and the European Blood and Marrow Transplanta- 36. Brunstein CG, Barker JN, Weisdorf DJ, et al: Umbilical cord blood
tion Group. N Engl J Med 337(6):373–381, 1997. transplantation after nonmyeloablative conditioning: impact on trans-
16. Laughlin MJ, Barker J, Bambach B, et al: Hematopoietic engraftment plantation outcomes in 110 adults with hematologic disease. Blood
and survival in adult recipients of umbilical-cord blood from unrelated 110(8):3064–3070, 2007.
donors. N Engl J Med 344(24):1815–1822, 2001. 37. Barker JN, Abboud M, Rice RD, et al: A “no-wash” albumin-dextran
17. Michel G, Rocha V, Chevret S, et al: Unrelated cord blood transplanta- dilution strategy for cord blood unit thaw: high rate of engraftment
tion for childhood acute myeloid leukemia: a Eurocord Group analysis. and a low incidence of serious infusion reactions. Biol Blood Marrow
Blood 102(13):4290–4297, 2003. Transplant 15(12):1596–1602, 2009.
18. Rubinstein P, Carrier C, Scaradavou A, et al: Outcomes among 562 38. Barker JN, Fei M, Karanes C, et al: Results of a prospective multicentre
recipients of placental-blood transplants from unrelated donors. N Engl myeloablative double-unit cord blood transplantation trial in adult
J Med 339(22):1565–1577, 1998. patients with acute leukaemia and myelodysplasia. Br J Haematol
19. Wagner JE, Barker JN, DeFor TE, et al: Transplantation of unrelated 168(3):405–412, 2015.
donor umbilical cord blood in 102 patients with malignant and non- 39. Somers JA, Braakman E, van der Holt B, et al: Rapid induction of single
malignant diseases: influence of CD34 cell dose and HLA disparity donor chimerism after double umbilical cord blood transplantation
on treatment-related mortality and survival. Blood 100(5):1611–1618, preceded by reduced intensity conditioning: results of the HOVON
2002. 106 phase II study. Haematologica 99(11):1753–1761, 2014.
20. Gluckman E, Rocha V: Cord blood transplantation for children with 40. Ballen KK, Spitzer TR, Yeap BY, et al: Double unrelated reduced-
acute leukaemia: a Eurocord registry analysis. Blood Cells Mol Dis intensity umbilical cord blood transplantation in adults. Biol Blood
33(3):271–273, 2004. Marrow Transplant 13(1):82–89, 2007.
21. Rocha V, Gluckman E: Improving outcomes of cord blood transplanta- 41. Avery S, Shi W, Lubin M, et al: Influence of infused cell dose and HLA
tion: HLA matching, cell dose and other graft- and transplantation- match on engraftment after double-unit cord blood allografts. Blood
related factors. Br J Haematol 147(2):262–274, 2009. 117(12):3277–3285, quiz 3478, 2011.